Skip to content
bd@cod-research.com
+91 79 6947 8900
+1(732) 749-7719
Request for Proposal
About Us
Our Services
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Softwares
aRMM TREx
Insights & Resources
Blogs & Articles
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Event Insights
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
About Us
Our Servcies
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory Solutions — old
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Softwares
aRMM TREx
Insights & Resources
Blogs & Articles
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Event Insights
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
Insights & Resources
Home
|
Insights & Resources
Clinical Trials
Pharmacovigilance
Regulatory
Corporate Presentation
Quality Assurance
Brochure
Medical Affairs
Read More
Brochure
CT Quality Assurance
Read More
Brochure
Clinical Services
Read More
Brochure
Biometrics
Read More
Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial
Read More
Blog
Strategic Planning for Patient Recruitment
Read More
Article
Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment
Read More
EMA
FDA
MHRA
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 15 July 2026, 09:30 (CEST) to 15 July 2026, 13:30 (CEST)
Source: EMA
Published on 2026-10-01
Meeting summary - Medicine shortages SPOC working party meeting 15 July 2026
Source: EMA
Published on 2026-10-01
European Medicines Agency workshop on bacteriophage therapy, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 October 2026, 09:00 (CET) to 30 October 2026, 18:00 (CET)
Source: EMA
Published on 2026-10-01
Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, 20 November 2026
Source: EMA
Published on 2026-10-01
Advice on ‘end-of-year’ submission dates for type I variations in 2026
Source: EMA
Published on 2026-10-01
EMA Management Board: highlights of September 2026 meeting
Source: EMA
Published on 2026-10-01
Read More
FDA approves pembrolizumab for adenocarcinoma
Source: FDA
Published on 2025-04-08
Approved Drug Products with Therapeutic Equivalence Evaluations (Orang
Source: FDA
Published on 2025-04-08
Additions/Deletions for Prescription and OTC Drug Product Lists
Source: FDA
Published on 2025-04-08
Recalls small number of acne products for benzene contamination
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
Read More
Class 4 Medicines Defect Notification: Neuraxpharm UK Limited, Levetiracetam Neuraxpharm granules for oral solution in sachet, EL(26)A/40
Source: MHRA
Published on 2026-10-01
Field Safety Notices: 21 to 25 September 2026
Source: MHRA
Published on 2026-09-29
MHRA Safety Roundup: September 2026
Source: MHRA
Published on 2026-09-29
Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/39
Source: MHRA
Published on 2026-09-23
Field Safety Notices: 14 to 18 September 2026
Source: MHRA
Published on 2026-09-23
Radiofrequency (RF) Safety Considerations for Wireless Cardiotocography (CTG) Monitoring Systems (DSI/2026/012)
Source: MHRA
Published on 2026-09-17
Read More